Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study

Olga Tronina; Magdalena Durlik; Marta Wawrzynowicz-Syczewska; Arida Buivydiene; Krum Katzarov; Limas Kupcinskas; Ieva Tolmane; Ewa Karpińska; Arkadiusz Pisula; Kornelia Magdalena Karwowska; Beata Bolewska; Maciej Jabłkowski; Karolina Rostkowska; Jolita Jakutiene; Marieta Simonova; Robert Flisiak

doi:10.12659/AOT.903535

07 April 2017 : Original article

Real-World Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir/+Dasabuvir±Ribavirin (OBV/PTV/r/+DSV±RBV) Therapy in Recurrent Hepatitis C Virus (HCV) Genotype 1 Infection Post-Liver Transplant: AMBER-CEE Study

Olga Tronina^1ACDEF*, Magdalena Durlik^1C, Marta Wawrzynowicz-Syczewska^2BF, Arida Buivydiene^3B, Krum Katzarov^4A, Limas Kupcinskas^5BD, Ieva Tolmane^6D, Ewa Karpińska^2B, Arkadiusz Pisula^7F, Kornelia Magdalena Karwowska^8B, Beata Bolewska^9C, Maciej Jabłkowski^10A, Karolina Rostkowska^11C, Jolita Jakutiene^3D, Marieta Simonova^4E, Robert Flisiak^12ABDEFG

DOI: 10.12659/AOT.903535

Ann Transplant 2017; 22:199-207

Authors information Article notes Copyright and License information